Ulcerative colitis has a second incidence peak between ages 50 and 70. In one registry, elderly-onset UC was associated with all-cause mortality of 7.0% versus 1.0% in younger-onset disease, along with higher rates of C. difficile infection, colorectal cancer, and venous thromboembolism. AAVBC’s perspective is that older-onset UC is not simply younger-onset disease occurring later. It is harder to distinguish from mimics, more vulnerable to undertreatment, and more sensitive to infection, frailty, polypharmacy, and immunosuppression-related harm. Primary care teams should document disease extent and complications precisely while helping keep steroid-sparing therapy, VTE risk, and cancer surveillance on track.
AAVBC's Ulcerative Colitis Quick Reference Guide translates the ACG 2025 guideline and AGA 2024 living guideline into practical support for ICD-10 subsite and complication coding, therapy escalation, MEAT documentation, extraintestinal manifestations, and colorectal cancer and VTE surveillance.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of ulcerative colitis — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
Ulcerative colitis has a second incidence peak between ages 50 and 70. In one registry, elderly-onset UC was associated with all-cause mortality of 7.0% versus 1.0% in younger-onset disease, along with higher rates of C. difficile infection, colorectal cancer, and venous thromboembolism. AAVBC’s perspective is that older-onset UC is not simply younger-onset disease occurring later. It is harder to distinguish from mimics, more vulnerable to undertreatment, and more sensitive to infection, frailty, polypharmacy, and immunosuppression-related harm. Primary care teams should document disease extent and complications precisely while helping keep steroid-sparing therapy, VTE risk, and cancer surveillance on track.
AAVBC's Ulcerative Colitis Quick Reference Guide translates the ACG 2025 guideline and AGA 2024 living guideline into practical support for ICD-10 subsite and complication coding, therapy escalation, MEAT documentation, extraintestinal manifestations, and colorectal cancer and VTE surveillance.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of ulcerative colitis — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
